Divoux, Jordane
Florent, Romane
Jacobs, Margaux
Lequesne, Justine
Grellard, Jean-Michel
San, Chankannira
Grossi, Sara
Kerdja, Katia
Clarisse, Bénédicte
Boudier, Gwenaelle
Cherifi, François
Briand, Mélanie
Dolivet, Enora
Johnson, Alisson
Dubois, Brice
Harter, Valentin
Lacroix, Joëlle
Raboutet, Charlotte
Marie, Brigitte
Rousseau, Nathalie
Blanc-Fournier, Cécile
Vaur, Dominique
Figeac, Martin
Poulain, Laurent
Weiswald, Louis-Bastien
Emile, George
Funding for this research was provided by:
Normandy County Council (ORGATHEREX)
Rochambelle
Article History
Received: 17 July 2023
Accepted: 1 September 2023
First Online: 19 September 2023
Declarations
:
: This study and all its methods will be carried out in accordance with relevant guidelines and have received ethical approval from the Comité de Protection des Personnes Nord-Ouest I (N°EudraCT: 2021-A02676-35) in June 2022. This committee is independent and not related with any affiliation of the authors. Any subsequent will of modification of the protocol would be submitted to agreement of the committee. The clinical trial has been registered at ClinicalTrials.gov with the identifier NCT05404321 on June 3rd 2022. The study will be explained to the patients by the oncologists and an informed consent form will be obtained from all participants.
: Not applicable.
: The authors declare no competing interests.